BIOPHARMACEUTICAL PREPARATIONS USE

Brand Owner (click to sort) Address Description
CARING FOR LIFE FRESENIUS KABI AG Else-Kroener-Str. 1 Bad Homburg 61352 Germany Biopharmaceutical preparations for use in the treatment of tissue and organ transplants; Medical fluids for organ perfusion and preservation; Immunosuppression agents; Pharmaceutical and sanitary preparations for dialysis therapy; pharmaceutical preparations for the treatment of chronic kidney disease; nutritional supplements; Pharmaceutical solutions used in dialysis;
CARING FOR LIFE FRESENIUS KABI AG Else-Kroener-Str. 1 Bad Homburg 61352 Germany Biopharmaceutical preparations for use in the treatment of immunological conditions; Biopharmaceutical preparations for use in the treatment of tumors; Biopharmaceutical preparations for use in the treatment of immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; Pharmaceutical preparations, namely, enteral and parenteral nutrition, admixtures to parenteral nutrition [ and compound of parenteral nutrition; compound of intravenous drugs, namely, pharmaceutical preparations as a constituent of compound of pharmaceuticals for use in nutritional therapy, immune therapy, pain therapy, cancer therapy, the treatment of infectious diseases, the treatment of blood and blood volume; ] infusion solutions for the delivery of drugs and pharmaceutical preparations, namely, for parenteral nutrition, for use in nutritional therapy, immune therapy, pain therapy, cancer therapy, the treatment of infectious diseases, the treatment of blood [ and blood volume, ] the treatment of oedema and for use in anaesthesia; standard infusion solutions for [ blood volume replacement and ] drug reconstitution; pharmaceutical preparations, namely, rinsing solutions for washing purposes, [ blood volume expanders, ] antibiotics, anti-infectives, analgesics and anaesthetics; injectable critical care drugs, namely, anti-infectives, anaesthesia and analgesia for critical care; [ oral drugs, namely, antibiotics, anti-infectives, analgesics and anaesthetics; ] pharmaceutical preparations used in oncology; medical packaging sets comprising bags, bottles, structural parts and replacement parts filled with pharmaceutical preparations [ and dietetic products for enteral ] and parenteral nutrition, admixtures to parenteral nutrition; clinical medical reagents for processing human blood for use in blood transfusions stored in bags; [ Pharmaceutical preparations for the treatment of blood volume; ] Intravenous fluids for nutrition and the delivery of pharmaceutical preparations; blood bank accessories for medical use, namely, solutions for the storage and washing of medical devices used in blood procedures;
DESENSIN TANOX BIOSYSTEMS, INC. 10301 Stella Link Houston TX 77025 biopharmaceutical preparations for use in treating diseases associated with allergies;
DESENSIN TANOX BIOSYSTEMS, INC. 10301 Stella Link Houston TX 77025 biopharmaceutical preparations for use in the treatment of allergic diseases, including asthma, allergic rhinitis, and atopic dermatitis;
FRESENIUS BIOTECH FRESENIUS SE & CO. KGAA Else-Kroener-Str. 1 Bad Homburg 61352 Germany Biopharmaceutical preparations for use in the treatment of immunological conditions; Biopharmaceutical preparations for use in the treatment of tissue and organ transplants; Biopharmaceutical preparations for use in the treatment of tumors; Biopharmaceutical preparations for use in the treatment of immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; Medical fluids for organ perfusion and preservation; Immunosupression agents for use in organ transplantation; trifunctional antibodies for cancer treatment;FRESENIUS BIO TECH;Color is not claimed as a feature of the mark.;Medical services; medical services, namely, cell and gene therapy; Medical services, namely, vector production gene therapy;BIOTECH;
GRAFALON Neovii Biotech NA, Inc. 920 Winter Street Waltham MA 024511457 Biopharmaceutical preparations for use in the treatment of immunological conditions; biopharmaceutical preparations for use in the treatment of tissue and organ transplants; biopharmaceutical preparations for use in the treatment of tumors; biopharmaceutical preparations for use in the treatment of immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; biopharmaceutical preparations for use in stem cell transplant procedures;Medical services, namely, oncology, stem cell transplantation and immunological therapy;
HYBRIDOMICS Viventia Biotech Inc. 10 Four Seasons Place, Suite 501 Toronto, Ontario M9B 6H7 Canada BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF CANCER, INFECTIOUS DISEASE AND AUTOIMMUNE DISEASE, INCLUDING HYBRIDOMA-GENERATED ANTIBODIES AND MAMMALIAN ANTIBODIES INCLUDING HUMAN ANTIBODIES; BIOPHARMACEUTICAL AND BIOTECHNOLOGY REAGENTS FOR MEDICAL DIAGNOSTIC USE;CHEMICAL PRODUCTS FOR USE IN MANUFACTURING IN THE BIOPHARMACEUTICAL INDUSTRY AND BIOTECHNOLOGY INDUSTRY; BIOPHARMACEUTICAL AND BIOTECHNOLOGICAL REAGENTS FOR SCIENTIFIC AND MEDICAL RESEARCH USE;MEDICAL AND SCIENTIFIC RESEARCH SERVICES INCLUDING PREPARATION AND DEVELOPMENT OF HYBRIDOMA-DERIVED ANTIBODIES AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS;
LEUKINE LIQUID IMMUNEX CORPORATION One Amgen Center Drive Thousand Oaks CA 913201799 biopharmaceutical preparations for use in the treatment of cancer and immune system diseases;LIQUID;The stippling in the mark is a feature of the mark and is not intended to represent color.;
MINE Advaxis, Inc. 305 College Road East Princeton NJ 08540 BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNOLOGICAL CONDITIONS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF TUMORS; BIOPHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF IMMUNE SYSTEM CONDITIONS; MEDICINAL PREPARATIONS FOR THE TREATMENT OF INFECTIOUS DISEASES AND FOR USE IN ONCOLOGY; BIOPHARMACEUTICAL PREPARATIONS FOR PERSONALIZED CANCER IMMUNOTHERAPIES AND IMMUNO-ONCOLOGY THERAPIES;PHARMACEUTICAL AND MEDICAL RESEARCH AND DEVELOPMENT IN THE FIELDS OF PHARMACEUTICAL AND BIOLOGICAL PREPARATIONS USED IN THE DIAGNOSIS AND TREATMENT OF CANCER AND PHARMACEUTICAL AND BIOLOGICAL PREPARATIONS USED IN ACTIVE SPECIFIC IMMUNOTHERAPY FOR THE TREATMENT OF CANCER; PROVIDING MEDICAL AND SCIENTIFIC RESEARCH INFORMATION IN THE FIELDS OF PHARMACEUTICALS, BIOLOGICALS, AND CLINICAL TRIALS; PROVIDING IMMUNOTHERAPY AND IMMUNO-ONCOLOGY PLATFORMS IN THE NATURE OF THE DEVELOPMENT OF BIOCHEMICAL ASSAYS FOR THE TREATMENT OF IMMUNE SYSTEM CONDITIONS AND CANCER;
NEOVII Neovii Biotech NA, Inc. 920 Winter Street Waltham MA 024511457 Biopharmaceutical preparations for use in the treatment of immunological conditions; biopharmaceutical preparations for use in the treatment of tissue and organ transplants; biopharmaceutical preparations for use in the treatment of tumors; biopharmaceutical preparations for use in the treatment of immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; medical fluids for organ perfusion and preservation; immunosuppression agents for use in organ transplantation; trifunctional antibodies for cancer treatment; biopharmaceutical preparation for use in enzyme replacement therapy; biopharmaceutical preparations for personalized protein delivery platforms;The wording NEOVII has no meaning in a foreign language.;Medical services; medical services, namely, cell and gene therapy; medical services, namely, vector production gene therapy; medical services, namely, metabolic disorder therapy;
NEOVII BIOTECH Neovii Biotech NA, Inc. 920 Winter Street Waltham MA 024511457 Biopharmaceutical preparations for use in the treatment of immunological conditions; biopharmaceutical preparations for use in the treatment of tissue and organ transplants; biopharmaceutical preparations for use in the treatment of tumors; biopharmaceutical preparations for use in the treatment of immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; medical fluids for organ perfusion and preservation; immunosuppression agents for use in organ transplantation; trifunctional antibodies for cancer treatment; biopharmaceutical preparation for use in enzyme replacement therapy; biopharmaceutical preparations for personalized protein delivery platforms;NEOVII BIO TECH;The wording NEOVII has no meaning in a foreign language.;Medical services; medical services, namely, cell and gene therapy; medical services, namely, vector production gene therapy; medical services, namely, metabolic disorder therapy;BIOTECH;
OXURION Oxurion NV Gaston Geenslaan 1 B-3001 Heverlee Belgium Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops;Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services;Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals;
OXURION ThromboGenics Gaston Geenslaan 1 B-3001 Leuven Belgium Biopharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; diagnostic medical reagents, chemicals preparations and biological materials all the foregoing being in the form of spatially defined arrays and solutions and reagents for medical laboratory use in diagnosting, monitoring, and predicting diseases and for measuring and predicting response to therapy of cardiac and vascular diseases; pharmaceutical preparations for use in the treatment of hypertension, strokes, cardiac diseases and vascular diseases; pharmaceutical substances and medicines for treatment or prevention of eye disorders and diseases and of ophthalmological disorders and diseases; pharmaceutical preparations and substances for the treatment or prevention of diabetes; medicines for treating or preventing diabetes; ophthalmic medicines and surgical fluids, ophthalmic pharmaceutical preparations; pharmaceutical eye drops;Medical services; veterinary services; consultancy services, namely, consultancy in the medical, veterinary and pharmaceutical treatment of patients in the fields of ophthalmology, diabetes and cardiovascular diseases; medical services, namely, cardiac and vascular therapeutic, prognostic and diagnostic testing services;Scientific and technological services, namely research and design relating thereto in the field of ophthalmology, in the field of diabetes and in the field of treatment of cardiovascular disease, cardiac disease and vascular disease; industrial analysis of the pharmaceutical preparations of others used for the treatment of ophthalmologic diseases, diabetes and cardiovascular diseases for quality control purposes; research services in the field of ophthalmology, diabetes and cardiovascular diseases; pharmaceutical and biopharmaceutical research and development; biopharmaceutical product evaluation; research in the field of treatment of cardiovascular disease, cardiac disease, and vascular disease; development of new treatments for pathologies in which vascular biology plays a critical role in the field of biopharmaceuticals;
VIVENTIA Viventia Biotech Inc. 10 Four Seasons Place, Suite 501 Toronto, Ontario M9B 6H7 Canada [ Biopharmaceutical preparations for use in immunotherapy, including monoclonal antibodies and fragments thereof and immunofusions and immunoconjugates, particularly immunoligands for the detection and treatment of cancer, biotechnology products for use immunotherapy, including monoclonal antibodies and fragments thereof and immunofusions and immunoconjugates, particularly immunoligands for the detection and treatment of cancer ];[ Chemical and biological preparations for use in the manufacture of biopharmaceutical and biotechnology products ];Medical services; research and product development; medical services used in connection with the biopharmaceutical and biotechnology industries;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. Propofol solubilised in aqueous micellar preparations of poloxamers is stable at low concentrations and that such preparations are effective administration forms for Propofol.